Lv41
490 积分 2023-08-27 加入
Frailty and risk of metabolic dysfunction–associated steatotic liver disease and other chronic liver diseases
2天前
已完结
End-of-treatment HBcrAg and HBsAb levels identify durable functional cure after Peg-IFN-based therapy in patients with CHB
1个月前
已完结
Similarly low risk of hepatocellular carcinoma after either spontaneous or nucleos(t)ide analogue‐induced hepatitis B surface antigen loss
2个月前
已完结
Inhibition of sodium-glucose cotransporter-2 and liver-related complications in individuals with diabetes: a Mendelian randomization and population-based cohort study
3个月前
已完结
Getting to HBV Cure – will new biomarkers help?
4个月前
已完结
抗病毒治疗后慢性乙型肝炎HBsAg阴转的预测因子
4个月前
已完结
Hepatitis B
4个月前
已完结
Factors Associated With Rates of HBsAg Seroclearance in Adults With Chronic HBV Infection: A Systematic Review and Meta-analysis
4个月前
已完结
Factors Associated With Rates of HBsAg Seroclearance in Adults With Chronic HBV Infection: A Systematic Review and Meta-analysis
4个月前
已关闭
Safety and efficacy of tirofiban versus traditionaldualantiplatelettherapy in endovasculartreatment of intracranialaneurysms: asystematicreview and meta-analysis
4个月前
已完结
皖公网安备34019202002308
